PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1

  • Gerhard Fischer (Creator)
  • Daniel Peter (Boehringer Ingelheim RCV GmBH & Co KG) (Creator)
  • Silvia Arce-Solano (Boehringer Ingelheim RCV GmBH & Co KG) (Creator)
  • Alessio Ciulli (Creator)

Dataset

Data Monitor categories

  • Drug development
  • Targeting cancer with small molecule pan-KRAS degraders

    Popow, J., Farnaby, W., Gollner, A., Kofink, C., Fischer, G., Wurm, M., Zollman, D., Wijaya, A., Mischerikow, N., Hasenoehrl, C., Prokofeva, P., Arnhof, H., Arce-Solano, S., Bell, S., Boeck, G., Diers, E., Frost, A. B., Goodwin-Tindall, J., Karolyi-Oezguer, J. & Khan, S. & 23 others, Klawatsch, T., Koegl, M., Kousek, R., Kratochvil, B., Kropatsch, K., Lauber, A. A., McLennan, R., Olt, S., Peter, D., Petermann, O., Roessler, V., Stolt-Bergner, P., Strack, P., Strauss, E., Trainor, N., Vetma, V., Whitworth, C., Zhong, S., Quant, J., Weinstabl, H., Kuster, B., Ettmayer, P. (Lead / Corresponding author) & Ciulli, A. (Lead / Corresponding author), 20 Sept 2024, In: Science. 385, 6715, p. 1338-1347 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    19 Citations (Scopus)
    242 Downloads (Pure)

Cite this